In recent years, the field of oncology has increasingly acknowledged cancer as a metabolic disorder with significant ...
A new industry partnership—between the companies EpiCypher and AtlasXomics—marries one technology that allows for investigation of the epigenome together with a spatial technology that enables ...
The Cancer Prevention and Research Institute (CPRIT) of Texas is supporting a Comprehensive Epigenomics Cancer Core Facility that provides consultation, instrumentation, technical support and data ...
Dr. Behrens articulates a philosophy of science that prioritizes teamwork over hierarchy. She describes her greatest talent as building collaborative teams where everyone contributes without regard to ...
U.S. FDA advisers back approval for Guardant's blood-based cancer test Advisers to the U.S. Food and Drug Administration on Thursday recommended for the approval of Guardant Health's blood test to ...